U.S. Cannabis Market Size, Share & Trends Analysis Report By End-use (Medical, Recreational, Industrial), By Source (Marijuana, Hemp), By Derivative (CBD, THC), And Segment Forecasts, 2022 - 2030

June 2022 | 150 pages | ID: U5CCF9C33399EN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 4 Business Days

Vaginal Rejuvenation Market Growth & Trends

The global vaginal rejuvenation market is expected to reach USD 4.7 billion by 2030, according to a new report by Grand View Research, Inc. The Growing popularity of vaginal rejuvenation surgery due to the risi

Contents

CHAPTER 1 RESEARCH METHODOLOGY AND SCOPE

1.1 Research Process
1.2 Information Procurement
  1.2.1 Purchased database:
    1.2.1.1 GVR’s internal database
  1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 List to Data Sources

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 The U.S. Cannabis Market Snapshot

CHAPTER 3 U.S. CANNABIS MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 The U.S. Cannabis Market Dynamics
  3.3.1 Market Driver Analysis
  3.3.2 Market Restraints Analysis
  3.3.4 Opportunity Analysis (2016-2021-2030)
  3.3.5 The U.S. Cannabis Industry Case Study
    3.3.5.1 Legalization of Cannabis:
    3.3.5.2 Reason for Legalization:
    3.3.5.3 Scenario After Legalization and Consumer Attitudes:
    3.3.5.4 Competitive Landscape Post Legalization:
  3.3.6 The U.S. Cannabis Regulatory Scenario
  3.3.7 The U.S. Cannabis Market - PESTLE Analysis
  3.3.8 Industry Analysis - Porter’s

CHAPTER 4 U.S. CANNABIS MARKET: END-USE ESTIMATES & TREND ANALYSIS

4.1 Cannabis Market: End-Use Movement Analysis
4.2 Medical
  4.2.1 Medical market estimates and forecasts, 2016 - 2030 (USD Million)
  4.2.2 Cancer
    4.2.2.1 Cancer Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.3. Chronic Pain
    4.2.3.1 Chronic Pain Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.4 Depression And Anxiety
    4.2.4.1 Depression And Anxiety Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.5 Arthritis
    4.2.5.1 Arthritis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.6 Diabetes
    4.2.6.1 Diabetes Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.7 Glaucoma
    4.2.7.1 Glaucoma Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.8 Migraines
    4.2.8.1 Migraines Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.9 Epilepsy
    4.2.9.1 Epilepsy Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.10 Multiple Sclerosis
    4.2.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.11 AIDS
    4.2.11.1 AIDS Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.12 Amyotrophic Lateral Sclerosis
    4.2.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.13 Alzheimer's
    4.2.13.1 Alzheimer's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.14 Post Traumatic Stress Disorder (Ptsd)
    4.2.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.15 Parkinson's
    4.2.15.1 Parkinson's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.16 Tourette’s
    4.2.16.1 Tourette’s Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  4.2.17 Others
    4.2.17.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.3 Recreational
  4.3.1 Recreational market estimates and forecasts, 2016 - 2030 (USD Million)
4.4 Industrial
  4.4.1 Industrial market estimates and forecasts, 2016 - 2030 (USD Million)

CHAPTER 5 U.S. CANNABIS MARKET: SOURCE TYPE ESTIMATES & TREND ANALYSIS

5.1 U.S. Cannabis Market: Source Type Movement Analysis
5.2 Marijuana
  5.2.1 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
  5.2.2 Flowers
    5.2.2.1 Flowers Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  5.2.3 Oil And Tinctures
    5.2.3.1 Oil And Tinctures Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.3 Hemp
  5.3.1 Hemp market estimates and forecasts, 2016- 2030 (USD Million)
  5.3.2 Hemp CBD
    5.3.2.1 Hemp CBD Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  5.3.3 Supplements
    5.3.3.1 Supplements Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  5.3.4. Industrial Hemp
  5.3.4..1 Industrial Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)

CHAPTER 6 U.S. CANNABIS MARKET: DERIVATIVE ESTIMATES & TREND ANALYSIS

6.1 U.S. Cannabis Market: Derivative Movement Analysis
6.2 CBD
  6.2.1 CBD market estimates and forecasts, 2016 – 2030 (USD Million)
6.3 THC
  6.3.1 CBD market estimates and forecasts, 2016 - 2030 (USD Million)
6.4 Others
  6.4.1 Other market estimates and forecasts, 2016 - 2030 (USD Million)

CHAPTER 7 COMPETITIVE LANDSCAPE

7.1 Company Profiles
  7.1.1 CANOPY GROWTH CORPORATION
    7.1.1.1 Funding
    7.1.1.2 Number of Employees
    7.1.1.3 Headquarters
    7.1.1.4 Business Model (Product Offerings)
    7.1.1.5 Growers, Manufacturers, Retailers
    7.1.1.6 Revenue 2020(USD Mn)
    7.1.1.7 Net Loss 2020 (USD Mn
    7.1.1.8 Valuation (USD Mn)
    7.1.1.9 Regions With Commercial Presence
  7.1.2 GW PHARMACEUTICALS, PLC
    7.1.2.1 Funding
    7.1.2.2 Number of Employees
    7.1.2.3 Headquarters
    7.1.2.4 Business Model (Product Offerings)
    7.1.2.5 Growers, Manufacturers, Retailers
    7.1.2.6 Revenue 2020(USD Mn)
    7.1.2.7 Net Loss 2020 (USD Mn
    7.1.2.8 Valuation (USD Mn)
    7.1.2.9 Regions With Commercial Presence
  7.1.3 AURORA CANNABIS, INC.
    7.1.3.1 Funding
    7.1.3.2 Number of Employees
    7.1.3.3 Headquarters
    7.1.3.4 Business Model (Product Offerings)
    7.1.3.5 Growers, Manufacturers, Retailers
    7.1.3.6 Revenue 2020(USD Mn)
    7.1.3.7 Net Loss 2020 (USD Mn
    7.1.3.8 Valuation (USD Mn)
    7.1.3.9 Regions With Commercial Presence
  7.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)
    7.1.4.1 Funding
    7.1.4.2 Headquarters
    7.1.4.3 Business Model (Product Offerings)
    7.1.4.4 Growers, Manufacturers, Retailers
    7.1.4.5 Valuation (USD Mn)
    7.1.4.6 Regions With Commercial Presence
  7.1.5 CRONOS GROUP
    7.1.5.1 Funding
    7.1.5.2 Number of Employees
    7.1.5.3 Headquarters
    7.1.5.4 Business Model (Product Offerings)
    7.1.5.5 Growers, Manufacturers, Retailers
    7.1.5.6 Revenue 2020(USD Mn)
    7.1.5.7 Net Loss 2020 (USD Mn
    7.1.5.8 Valuation (USD Mn)
    7.1.5.9 Regions With Commercial Presence
  7.1.6 TILRAY
    7.1.6.1 Funding
    7.1.6.2 Number of Employees
    7.1.6.3 Headquarters
    7.1.6.4 Business Model (Product Offerings)
    7.1.6.5 Growers, Manufacturers, Retailers
    7.1.6.6 Revenue 2020(USD Mn)
    7.1.6.7 Net Loss 2020 (USD Mn
    7.1.6.8 Valuation (USD Mn)
    7.1.6.9 Regions With Commercial Presence

List Of Tables

LIST OF TABLES

Table 1 U.S. cannabis market, by cannabis type, 2016 - 2030 (USD Million)
Table 2 U.S. cannabis market, by product type, 2016 - 2030 (USD Million)
Table 3 U.S. cannabis market, by medical application, 2016 - 2030 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 U.S. Cannabis market snapshot, 2021 (USD Million)
Fig. 2 U.S. Cannabis market Snapshot
Fig. 3 U.S. Cannabis market segmentation
Fig. 4 U.S. Cannabis market dynamics
Fig. 5 U.S. Cannabis market driver impact
Fig. 6 U.S. Cannabis market restraints impact
Fig. 7 Penetration & growth prospects mapping for cannabis
Fig. 8 Opportunity Analysis (USD Million)
Fig. 9 U.S. Cannabis market - PESTLE analysis
Fig. 10 U.S. Cannabis market - Porter’s Analysis
Fig. 11 U.S. Cannabis market, cannabis type outlook: Key takeaways
Fig. 12 U.S. Cannabis market: End-Use movement analysis (2021 & 2030)(USD Million)
Fig. 13 Medical market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 14 Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 15 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 16 Depression and anxiety market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 17 Arthritis market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 18 Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 19 Glaucoma market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 20 Migraines market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 21 Epilepsy market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 22 Multiple Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 23 AIDS market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 24 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 25 Alzheimer's market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 26 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 27 Parkinson's market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 28 Tourette’s market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 30 Recreational market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 31 Industrial market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 32 U.S. Cannabis market, Source type outlook: Key takeaways
Fig. 33 U.S. Cannabis market: Source movement analysis (2021 & 2030) (USD Million)
Fig. 34 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 35 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 36 Oil and tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 37 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 38 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 39 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 40 Industrial Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 41 U.S. Cannabis market, Derivative type outlook: Key takeaways
Fig. 42 U.S. Cannabis market: Derivative movement analysis (2021 & 2030) (USD Million)
Fig. 43 CBD market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 44 THC market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 45 Others market estimates and forecasts, 2016 - 2030 (USD Million)